Use of the Montreal global definition as an assessment of quality of life in reflux disease

Diseases of the Esophagus

Volumn 25, Issue 6, 2012, Pages 477-483

  Sawaya, R A ^a   Macgill, A ^a   Parkman, H P ^a   Friedenberg, F K ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Gastroesophageal reflux disease; Montreal global definition; Quality of life

Indexed keywords

PROTON PUMP INHIBITOR;

ACID REFLUX; ADULT; AGED; ARTICLE; CORRELATION ANALYSIS; EATING DISORDER; EMOTIONAL STRESS; ESOPHAGITIS; ESOPHAGOGASTRODUODENOSCOPY; FEMALE; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL ENDOSCOPY; HEARTBURN; HUMAN; MAJOR CLINICAL STUDY; MALE; PH MEASUREMENT; PHYSICAL ACTIVITY; PRIORITY JOURNAL; QUALITY OF LIFE; QUALITY OF LIFE IN REFLUX AND DYSPEPSIA; QUESTIONNAIRE; SCORING SYSTEM; SLEEP DISORDER; SOCIAL STATUS; VISUAL ANALOG SCALE; WELLBEING;

ADULT; AGED; AGED, 80 AND OVER; COST OF ILLNESS; ESOPHAGEAL PH MONITORING; FEMALE; GASTROESOPHAGEAL REFLUX; HEARTBURN; HUMANS; LARYNGOPHARYNGEAL REFLUX; MALE; MIDDLE AGED; QUALITY OF LIFE; SEVERITY OF ILLNESS INDEX;

EID: 84865045214     PISSN: 11208694     EISSN: 14422050     Source Type: Journal    
DOI: 10.1111/j.1442-2050.2011.01271.x     Document Type: Article

References (27)

1. Dent J, El-Serag H B, Wallander M A, Johansson S. Epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut 2005; 54: 710-7.
2. Ofman J J. The economic and quality-of-life impact of symptomatic gastroesophageal reflux disease. Am J Gastroenterol 2003; 98: S8-S14.
3. Nebel O T, Fornes M F, Castell D O. Symptomatic gastroesophageal reflux: incidence and precipitating factors. Am J Dig Dis 1976; 21: 953-6.
4. Carlsson R, Dent J, Bolling-Sternevald E etal. The usefulness of a structured questionnaire in the assessment of symptomatic gastroesophageal reflux disease. Scand J Gastroenterol 1998; 33: 1023-9.
5. Altman K W, Stephens R M, Lyttle C S, Weiss K B. Changing impact of gastroesophageal reflux in medical and otolaryngology practice. Laryngoscope 2005; 115: 1145-53.
6. Shaheen N J, Hansen R A, Morgan D R etal. The burden of gastrointestinal and liver diseases, 2006. Am J Gastroenterol 2006; 101: 2128-38.
7. Dimenas E, Glise H, Hallerback B, Hernqvist H, Svedlund J, Wiklund I. Well-being and gastrointestinal symptoms among patients referred to endoscopy owing to suspected duodenal ulcer. Scand J Gastroenterol 1995; 30: 1046-52.
8. Revicki D A, Wood M, Maton P N, Sorensen S. The impact of gastroesophageal reflux disease on health-related quality of life. Am J Med 1998; 104: 252-8.
9. Dimenas E, Glise H, Hallerback B, Hernqvist H, Svedlund J, Wiklund I. Quality of life in patients with upper gastrointestinal symptoms. An improved evaluation of treatment regimens? Scand J Gastroenterol 1993; 28: 681-7.
10. Dent J, Armstrong D, Delaney B, Moayyedi P, Talley N J, Vakil N. Symptom evaluation in reflux disease: workshop background, processes, terminology, recommendations, and discussion outputs. Gut 2004; 53 (Suppl 4): iv1-24.
11. Koop H, Schepp W, Muller-Lissner S etal. Consensus conference of the DGVS on gastroesophageal reflux. Z Gastroenterol 2005; 43: 163-4.
12. DeVault K R, Castell D O, American College of Gastroenterology. Updated guidelines for the diagnosis and treatment of gastroesophageal reflux disease. Am J Gastroenterol 2005; 100: 190-200.
13. Moraes-Filho J, Cecconello I, Gama-Rodrigues J etal. Brazilian consensus on gastroesophageal reflux disease: proposals for assessment, classification, and management. Am J Gastroenterol 2002; 97: 241-8.
14. Armstrong D, Marshall J K, Chiba N etal. Canadian Consensus Conference on the management of gastroesophageal reflux disease in adults - update 2004. Can J Gastroenterol 2005; 19: 15-35.
15. Vakil N, van Zanten S V, Kahrilas P, Dent J, Jones R, Global Consensus Group. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol 2006; 101: 1900-20; quiz 1943.
16. Wiklund I, Carlsson J, Vakil N. Gastroesophageal reflux symptoms and well-being in a random sample of the general population of a Swedish community. Am J Gastroenterol 2006; 101: 18-28.
17. Irvine E J. Quality of life assessment in gastro-oesophageal reflux disease. Gut 2004; 53 (Suppl 4): iv35-9.
18. Wiklund I K, Junghard O, Grace E etal. Quality of life in reflux and dyspepsia patients. Psychometric documentation of a new disease-specific questionnaire (QOLRAD). Eur J Surg Suppl 1998; 583: 41-9.
19. Gunasekaran T, Tolia V, Colletti R B etal. Effects of esomeprazole treatment for gastroesophageal reflux disease on quality of life in 12- to 17-year-old adolescents: an international health outcomes study. BMC Gastroenterol 2009; 9: 84.
20. Kulich K R, Madisch A, Pacini F etal. Reliability and validity of the Gastrointestinal Symptom Rating Scale (GSRS) and Quality of Life in Reflux and Dyspepsia (QOLRAD) questionnaire in dyspepsia: a six-country study. Health Qual Life Outcomes 2008; 6: 12.
21. Locke G R, Talley N J, Weaver A L, Zinsmeister A R. A new questionnaire for gastroesophageal reflux disease. Mayo Clin Proc 1994; 69: 539-47.
22. Moayyedi P, Axon A T. The usefulness of the likelihood ratio in the diagnosis of dyspepsia and gastroesophageal reflux disease. Am J Gastroenterol 1999; 94: 3122-5.
23. Mattioli S, Pilotti V, Spangaro M etal. Reliability of 24-hour home esophageal pH monitoring in diagnosis of gastroesophageal reflux. Dig Dis Sci 1989; 34: 71-8.
24. Avidan B, Sonnenberg A, Schnell T G, Sontag S J. There are no reliable symptoms for erosive oesophagitis and Barrett's oesophagus: endoscopic diagnosis is still essential. Aliment Pharmacol Ther 2002; 16: 735-42.
25. Klauser A G, Schindlbeck N E, Muller-Lissner S A. Symptoms in gastro-oesophageal reflux disease. Lancet 1990; 335: 205-8.
26. Johannessen T, Petersen H, Kleveland P M etal. The predictive value of history in dyspepsia. Scand J Gastroenterol 1990; 25: 689-97.
27. Berstad A, Hatlebakk J G. The predictive value of symptoms in gastro-oesophageal reflux disease. Scand J Gastroenterol Suppl 1995; 211: 1-4.